Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $20.17 is 117.58% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 20.49||$ 22.17|
|Low:||$ 19.76||$ 9.27|
ETFs with NEO as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|1.64%||Invesco S&P Smallcap 600 Pure Growth ETF (RZG)||-1.24 (-1.06%)|
|1.25%||Invesco Russell 2000 Pure Growth ETF (PXSG)||+3.32 (9.82%)|
|0.43%||iShares Microcap ETF (IWC)||+1.81 (1.95%)|
|*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past 100 days.|
Company Description (as filed with the SEC)
NeoGenomics, Inc., a Nevada corporation (referred to individually as the "Parent Company" or collectively with its subsidiaries as "NeoGenomics", "we", "us", "our" or the "Company" in this Annual Report) is the registrant for SEC reporting purposes. Our common stock is listed on the NASDAQ Capital Market under the symbol "NEO". Overview We operate a network of cancer-focused genetic testing laboratories in the United States as well as a laboratories in Switzerland and Singapore. Our mission is to improve patient care through exceptional genetic and molecular testing services. Our vision is to become the World's leading cancer testing and information company by delivering uncompromising quality, exceptional service and innovative solutions. As of December 31, 2018, the Company has laboratory locations in Ft. ... More ...
Nasdaq Official Price
Apr. 23, 2019
Apr. 23, 2019